• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Former ArthroCare VPs skate on multi-million settlements

Former ArthroCare VPs skate on multi-million settlements

July 21, 2011 By MassDevice staff

ArthroCare

Two former executives of ArthroCare Corp. (NSDQ:ATRC) are skating on millions of dollars in penalties as part of settlement agreements for charges that they artificially inflated the company’s stock prices for two years.

John Raffle, the Austin, Texas-based company’s former senior VP of strategic business units, and David Applegate, former SVP and GM of ArthoCare’s spine division, were charged by the federal Securities & Exchange Commission with enacting a scheme to boost ATRC shares ahead of quarterly earnings releases between 2006 and the first quarter of 2008.

The duo allegedly created the scheme, which allegedly caused the company to "improperly record revenue from shipments of spine products to various distributors, even though the distributors often did not need the products or have the ability to pay for them," the SEC alleged. "Most of the improper transactions occurred at or near the end of quarters and were intended to enable ArthroCare to satisfy external revenue and earnings targets."

Raffle and Applegate agreed to settle the charges without admitting or denying guilt. The settlements imposed penalties of $2.1 million on Raffle and $728,000 on Applegate and barred each from serving as an officer or director of a publicly traded company for five years.

But, based on each man’s financial situation, all but a fraction of the penalties were waived. Raffle will pay just $175,000 — only 8.3 percent — and Applegate $55,000 — 7.6 percent.

That’s less for each than Raffle’s ex-wife, Kathy — not charged at all in the case — will pay in restitution for "$200,000 of incentive compensation and profits from sales of ArthroCare stock John Raffle obtained during the course of the earnings management scheme, which Kathy Raffle received in a divorce agreement," according to documents filed with the U.S. District Court for Western Texas.

Read more of MassDevice’s coverage of ArthroCare Corp.

In February, ArthroCare escaped a separate SEC probe with no admission of guilt, no financial penalty and a promise to be good from now on. An independent review of the alleged misconduct led to the departure of then-president and CEO Michael Baker in February 2009, along with Raffle and Applegate, who both resigned Dec. 19, 2008, according to court documents.

ArthroCare later sold off its spine business to NeuroTherm for $5.5 million. The company posted net earnings of $12.8 million, or 36 cents per diluted share, on revenue of $87.9 million during the three months ended March 31. That compares with net earnings of $8.8 million, or 24 cents per diluted share, on revenue of $89.1 million during the same period last year.

Filed Under: Legal News, News Well, Orthopedics, Spine Tagged With: ArthroCare Corp.

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy